StockData
Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc. (HRTX) stock

HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$0.27−0.01 (-3.26%)

Close on Nov 18, 2026Market cap $51.83MP/E –Yield –

Heron Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Heron Therapeutics's market cap was $66.34M on Nov 11, 2026, against $195.59M a year earlier. Over the last 5 years it ranged from $51.28M to $1.60B, with a median of $283.38M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$66.34M-69.7%
2025Dec 31, 2025$219.19M-5.7%
2024Dec 31, 2024$232.42M+8.7%
2023Dec 29, 2023$213.81M-53.6%
2022Apr 29, 2022$461.06M-47.2%
2021Dec 31, 2021$873.82M-54.3%
2020Dec 31, 2020$1.91B+2.9%
2019Dec 31, 2019$1.86B+5.2%
2018Dec 31, 2018$1.76B+97.2%
2017Dec 29, 2017$894.99M+84.1%
2016Dec 30, 2016$486.15M-41.9%
2015Dec 31, 2015$837.31M+247.9%
2014Dec 31, 2014$240.67M+75.2%
2013Dec 31, 2013$137.35M+63.5%
2012Apr 30, 2012$84.02M+481.4%
2011Jul 29, 2011$14.45M–

More Heron Therapeutics figures

See a number that looks wrong?